Amino-LNA, thio-LNA and alphaL-oxy-LN

Details for Australian Patent Application No. 2011201821 (hide)

Owner Santaris Pharma A/S

Inventors Christensen, Signe M.; Mikkelsen, Nikolaj Dam; Frieden, Miriam; Hansen, Henrik Frydenlund; Koch, Troels; Pedersen, Daniel-Sejer; Rosenbohm, Christoph; Thrue, Charlotte Albaek; Westergaard, Majken

Agent FB Rice

Pub. Number AU-A-2011201821

Parent 2003281969

Filing date 20 April 2011

Wipo publication date 19 May 2011

International Classifications

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

12 May 2011 Complete Application Filed

19 May 2011 Application Open to Public Inspection

  Published as AU-A-2011201821

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011201822-Method for recycling FT-wax-containing iron catalyst removed from a FischerTropsch reactor

2011201820-Modular CPR assist device